Paediatric sickle cell disease at a tertiary hospital in Malawi: a retrospective cross-sectional study

Chikondi Sharon Chimbatata1, Master Ro Chisale2,3, Alfred Bornwell Kayira3

  • 1Paediatrics, Mzuzu Central Hospital, Mzuzu, Northern Region, Malawi.

BMJ Paediatrics Open
|September 27, 2021
PubMed

Insights

Sickle cell disease (SCD) in Malawian children is characterized by anemia, sepsis, and painful crises. Painful crises increase hospital stay, highlighting the need for prompt diagnosis and management of SCD.

Area of Science:

  • Paediatric Hematology
  • Communicable Diseases Epidemiology
  • Public Health

Background:

  • Sickle cell disease (SCD) is a significant cause of childhood mortality and morbidity in Malawi.
  • Comprehensive literature on paediatric SCD in Malawi is scarce, necessitating further research.

Purpose of the Study:

  • To describe the clinical features, management, and outcomes of paediatric sickle cell disease in Malawi.
  • To identify factors associated with prolonged hospital stay and case fatality in children with SCD.

Main Methods:

  • Retrospective review of clinical files for paediatric patients diagnosed with SCD.
  • Descriptive statistics and logistic regression analyses were employed to analyze data.
  • Statistical tests (χ², Fisher's exact, binary logistic regression) were used to identify significant associations.

Main Results:

  • SCD accounted for 3.1% of paediatric hospitalizations, with 13.3% of cases newly diagnosed during the study period.
  • Common clinical features included anemia (94.1%), sepsis (79.5%), and painful crisis (54.3%).
  • Patients with painful crisis had a 1.7 times higher likelihood of prolonged hospital stay.

Conclusions:

  • Anemia, sepsis, and painful crisis are prevalent in paediatric SCD patients in Malawi.
  • Delayed diagnosis of SCD is a critical issue requiring urgent attention.
  • While in-hospital mortality is relatively low, it may not reflect the overall disease burden due to potential under-reporting.
Abstract